NASDAQ NMS - GLOBAL MARKET · BTMD
+0.82% · +$0.0100 · Vol 62.9K
After hours · updated 16:00:00 ET
Biote Corp

Biote Corp

Pharmaceuticals
$1.23
Card
Relationship Map

Follow $BTMD

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BTMD by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
BTMD
Biote Corp
Mon Sep 28 · session closed · Markets closed · resumes Tue 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

46/ 100
Veridion Score
Middle range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Mon Sep 28 · session closed · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BTMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BTMD catalysts
About Biote Corp
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Listed since
2022
Employees
223
Country
US

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.20
Day high
$1.25
Day low
$1.15
Previous close
$1.22
52W high
$3.19
-61.44% from high
52W low
$1.15
4% of range
Market cap
$35M
P/E
7.48×
EPS
$0.1113
Beta
0.86
Shares out
28.7M
Volume
62.9K
0.23× rel vol
Avg volume
270.2K
VWAP
$1.23
Price history computed in-house
1W
-7.17%
1M
-21.66%
3M
-34.92%
1Y
-58.86%
YTD
-52.69%
SMA 50 $1.67 · below
SMA 200 $2.01 · below
52W position 4%

BTMD overview

Loading financial statements
Loading BTMD Form 4 filings
Public disclosures

Congress activity in BTMD

No receipt-qualified Congressional disclosure is present for BTMD in the cached public ledger.

Federal contracts

BTMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BTMD in this window.
Lobbying spend

BTMD lobbying filings, year to date.

Registered lobbying filings matched to Biote Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BTMD in this window.
Loading news for BTMD
Analyst ratings
Sovereign unlock shows live analyst consensus for BTMD.
Options
Sovereign unlock shows live options positioning for BTMD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.